Skip To Content

ACD/Labs Blog

The rapid increase in biopharmaceutical approvals and sales indicates their tremendous opportunities in the coming years. Innovative software solutions play an essential role in unlocking that potential. Learn more about how ACD/Labs brings chemical intelligence to biopharmaceutical research in this blog post.

The pharmaceutical industry has renewed its interest in HTE these last few years. Leaders see it as a way to get medicines to patients faster, but they’re also attracted by the sheer quantity of data generated in parallel experiments. How and where should HTE be set up for maximum success? Read this blog for questions that should be considered.

Andrew Anderson, VP of Innovation & Informatics Strategy, recently spoke with Scientific Computing World about some of the challenges associated with data standardization and how the value of data can be realized. Here’s an overview of what he covered...

What will the Lab of the Future look like? Andrew Anderson offers his insights into how ACD/Labs is poised to deliver products and capabilities to help usher companies into this unknown future.

There are numerous ways that the 3D structure of a molecule can be elucidated, including the use of our own ACD/Structure Elucidator software. I had the chance to sit down with Dimitris Argyropoulos, our NMR Business Manager, after SMASH 2019 and discuss 3D structure elucidation and the technology involved in its current and future use.

Reliable structure verification of candidate molecules is at the very core of any successful chemical discovery or development program. NMR provides unprecedented levels of information for unraveling the actual structure of compounds, and is an essential tool for chemists to confirm that they made what they intended to make. Read on to learn about ACD/Labs' efforts in the area of structure verification.